產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時(shí)服務(wù)熱線
![NCI-N87 [N87] (人胃癌細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0169-1.jpg)
![NCI-N87 [N87] (人胃癌細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0169-2.jpg)
![NCI-N87 [N87] (人胃癌細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0169-3.jpg)
![NCI-N87 [N87] (人胃癌細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0169-4.jpg)
![NCI-N87 [N87] (人胃癌細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0169-5.jpg)
![NCI-N87 [N87] (人胃癌細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0169-6.jpg)
![NCI-N87 [N87] (人胃癌細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/product/cell-line-new.jpg)
產(chǎn)品概述
| 名稱 | NCI-N87 [N87] (人胃癌細(xì)胞) (STR鑒定正確) |
| 別稱 | NCI-N87 |
| 種屬 | 人 |
| 生長(zhǎng)特性 | 貼壁細(xì)胞 |
| 細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
| 凍存條件 | 凍存液：55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認(rèn)） |
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:2-1:3 |
| 推薦換液頻率 | 2-3次/周 |
| 背景描述 | NCI-N87細(xì)胞表達(dá)表面糖蛋白癌胚抗原(CEA)和TAG72，并且沒有左旋多巴胺脫羧酶(DDC)活性。NCI-N87細(xì)胞的血管活性的腸肽(VIP)受體活性極低并缺乏胃泌激素受體，它們表達(dá)蕈毒堿膽堿受體。沒有證據(jù)表明，NCI-N87細(xì)胞存在N-myc、L-myc、myb和EGF受體基因的重組。NCI-N87細(xì)胞表達(dá)的c-myc和c-erb-B2 RNA水平與其它細(xì)胞株相當(dāng)。以下基因NCI-N87細(xì)胞不表達(dá)：N-myc、L-myc、c-cis、IGF-2或胃泌激素釋放肽。據(jù)報(bào)道，NCI-N87細(xì)胞的植板率為4.3%。 |
| 年齡（性別） | 男性 |
| 組織來(lái)源 | 胃癌 |
| 細(xì)胞類型 | 腫瘤細(xì)胞 |
| 腫瘤類型 | 胃癌細(xì)胞 |
| 生物安全等級(jí) | BSL-1 |
| 倍增時(shí)間 | ~48-80 hours |
| 致瘤性 | Yes, the cells form tumors in athymic nude mice. |
| 受體表達(dá)情況 | acetylcholine, muscarinic, expressed |
| 保藏機(jī)構(gòu) | ATCC; CRL-5822 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X,Y CSF1PO 8,12 D2S1338 23,24 D3S1358 14 D5S818 12,13 D7S820 10,11 D8S1179 14 D13S317 8,11 D16S539 9,13 D18S51 17 D19S433 14,14.2 D21S11 30 FGA 20,21 PentaD 12 PentaE 5 TH01 9 TPOX 9,11 vWA 15,16 D6S1043 12 D12S391 16,21 D2S441 11,12 -
STR鑒定圖
-
參考文獻(xiàn)
-
RBBP8/CtIP suppresses P21 expression by interacting with CtBP and BRCA1 in gastric cancer(2019/10/21)
作者：Yang Yu, Lei Chen, Guiping Zhao
期刊：Oncogene
影響因子 ：8.756
引用產(chǎn)品：CL-0169
-
Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2/p-DRP1 and NRF2/GPX4 Axes(2024/01/06)
作者：Lixian Ding, Shuwei Dang, Mingjun Sun
期刊：FREE RADICAL BIOLOGY AND MEDICINE
DOI：10.1016/j.freeradbiomed.2024.01.002
影響因子 ：7.400
引用產(chǎn)品：CL-0169
-
Isorhamnetin Promotes MKN-45 Gastric Cancer Cell Apoptosis by Inhibiting PI3K-Mediated Adaptive Autophagy in a Hypoxic Environment(2021/07/16)
作者：Chenghao Li, Jiawei Li, Yan Li
期刊：Journal Of Agricultural And Food Chemistry
影響因子 ：6.100
-
Tumor-Derived Exosomal LINC01480 Upregulates VCAM1 Expression by Acting as a Competitive Endogenous RNA of miR-204-5p to Promote Gastric Cancer Progression(2023/12/22)
作者：Yu Zhang, Shan Guo, Tao Mao
期刊：ACS Biomaterials Science & Engineering
DOI：10.1021/acsbiomaterials.3c00394
影響因子 ：5.800
引用產(chǎn)品：CL-0169
-
ECHDC2 inhibits the proliferation of gastric cancer cells by binding with NEDD4 to degrade MCCC2 and reduce aerobic glycolysis(2024/05/23)
作者：Jiancheng He, Jianfeng Yi, Li Ji
期刊：MOLECULAR MEDICINE
DOI：10.1186/s10020-024-00832-9
影響因子 ：5.700
引用產(chǎn)品：CL-0169
-
Circ_0021087 acts as a miR-184 sponge and represses gastric cancer progression by adsorbing miR-184 and elevating FOSB expression(2021/06/02)
作者：Yin Yu, Hong Li, Chunhua Wu
期刊：European Journal Of Clinical Investigation
影響因子 ：5.500
-
Long noncoding RNA PSMA3-AS1 functions as a competing endogenous RNA to promote gastric cancer progression by regulating the miR-329-3p/ALDOA axis(2023/07/04)
作者：Liang Kan, Meiqi Yang, Huijing Zhang
期刊：Biology Direct
DOI：10.1186/s13062-023-00392-8
影響因子 ：5.500
-
LINC01354 enhances the metastatic ability of gastric cancer cells by adjusting miR-153-5p/CADM2 expression(2023/06/15)
作者：Fa Fang, Yin Gu, Jie Gao
期刊：American Journal of Cancer Research
DOI：PMID:37424819
影響因子 ：5.300
-
ESM1 Interacts with c-Met to Promote Gastric Cancer Peritoneal Metastasis by Inducing Angiogenesis(2023/12/30)
作者：Jiaoyang Yang, Gege Shu, Tao Chen
期刊：Cancers
影響因子 ：5.200
引用產(chǎn)品：CL-0169
-
Benzophenanthridine Alkaloid Chelerythrine Elicits Necroptosis of Gastric Cancer Cells via Selective Conjugation at the Redox Hyperreactive C-Terminal Sec498 Residue of Cytosolic Selenoprotein Thioredoxin Reductase(2023/09/28)
作者：Minghui Liu, Shibo Sun, Yao Meng
期刊：MOLECULES
影響因子 ：4.600
-
Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib(2019/3/12)
作者：Zhengxing Gao, Chunqing Song, Guangxin Li
期刊：Onco Targets and Therapy
影響因子 ：4.000
引用產(chǎn)品：CL-0169
-
Suppression of gastric cancer cell proliferation by miR-494-3p inhibitor-loaded engineered exosomes(2024/05/06)
作者：Limin Zhang, Yingwei Xue, Hongfeng Zhang
期刊：Heliyon
DOI：10.1016/j.heliyon.2024.e30803
影響因子 ：4.000
引用產(chǎn)品：CL-0169
-
Silencing of Nudix type 5 represses proliferation and invasion and enhances chemosensitivity of gastric carcinoma cells by affecting the AKT/GSK-3β/β-catenin pathway(2022/03/02)
作者：Dong Tan, Yafei Zhang
期刊：Toxicology And Applied Pharmacology
DOI：10.1016/j.taap.2022.115968
影響因子 ：3.800
-
YTHDF2 promotes gastric cancer progression and enhances chemoradiotherapy resistance(2024/04/14)
作者：Jian Yang, Yawen Chen, Yang He
期刊：DRUG DEVELOPMENT RESEARCH
影響因子 ：3.800
引用產(chǎn)品：CL-0169
-
ZNF521/EBF1 axis regulates AKR1B1 to promote the proliferation, migration, and invasion of gastric cancer cells(2022/11/17)
作者：Yu Cheng, Yi-Jiang Ni, Li-Ming Tang
期刊：KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
影響因子 ：3.300
-
Circ_0032821 Facilitates Gastric Cancer Cell Proliferation, Migration, Invasion and Glycolysis by Regulating MiR-1236-3p/HMGB1 Axis(2020/10/12)
作者：Lei Chen, Kun Chi, Huaguo Xiang
期刊：Cancer Management and Research
影響因子 ：3.300
引用產(chǎn)品：164210 164210-50 CL-0022 CL-0107 CL-0169 CL-0292 PB180120 PM150110
-
Homeobox Protein BarH-like 1 Promotes Gastric Cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178(2024/02/15)
作者：Yue Gu, Gang Chen, Xinwei Ning
期刊：DIGESTIVE DISEASES AND SCIENCES
DOI：10.1007/s10620-024-08312-0
影響因子 ：3.100
引用產(chǎn)品：CL-0169
-
Knockdown of Serum- and Glucocorticoid-Regulated Kinase 1 Enhances Cisplatin Sensitivity of Gastric Cancer Through Suppressing the Nuclear Factor Kappa-B Signaling Pathway.(2021/11/01)
作者：Jishui Zhang,?Wenhao Lv,?Yagang Liu
期刊：Balkan Medical Journal
DOI：10.5152/balkanmedj.2021.21114
影響因子 ：3.000
-
KBTBD2 promotes proliferation and migration of gastric cancer via activating EGFR signaling pathway(2024/01/04)
作者：Jishuang Ding, Wei Gao, Haiying Yang
期刊：PATHOLOGY RESEARCH AND PRACTICE
影響因子 ：2.800
引用產(chǎn)品：CL-0169
-
Oncogenic transmembrane protein 158 drives the PI3K/Akt signaling pathway to accelerate gastric cancer cell growth(2023/11/13)
作者：Xiaoting Cui, Jie Lu, Cuijuan Zhao
期刊：BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
DOI：10.1590/1414-431X2023e12943
影響因子 ：2.300
引用產(chǎn)品：CL-0169
-
Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis(2023/04/20)
作者：Peng Wei, Chen Lin, Liu Jie
期刊：Toxicology Research
影響因子 ：2.100
-
Knockdown of kinesin family member 2C restricts cell proliferation and induces cell cycle arrest in gastric cancer(2022/11/30)
作者：Shuai Li, Yulian Ma, Chen Wu, Xinfang Hou, Shuai Li, Yulian Ma, Chen Wu, Xinfang Hou
期刊：HISTOLOGY AND HISTOPATHOLOGY
影響因子 ：2.000
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識(shí)別碼示意圖
娜胡文君.png "邱國(guó)娜/胡文君")
.png "梅文強(qiáng)")
